The University of Chicago Header Logo

Fredric L. Coe

TitleProfessor
InstitutionUniversity of Chicago
DepartmentMedicine-Nephrology
AddressChicago IL 60637
vCardDownload vCard

    Collapse Overview 

    Collapse Biography 
    Collapse education and training
    University of Chicago, ChicagoBA06/1955Liberal Arts
    University of Chicago, ChicagoBS06/1957Biology
    University of Chicago, ChicagoMD06/1961Medicine
    Michael Reese Hospital, Chicago06/1965Medical Residency
    Univ. Texas SW Medical School, Dallas Texas06/1969Fellowship in Nephrology

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Prochaska M, Menezes C, Ko BS, Coe F, Worcester E, Prochaska M, Menezes C, Ko BS, Coe F, Worcester E. Contribution of thick ascending limb and distal convoluted tubule to glucose-induced hypercalciuria in healthy controls. Am J Physiol Renal Physiol. 2023 12 01; 325(6):F811-F816. PMID: 37823200; PMCID: PMC10874680.
      Citations:    Fields:    Translation:Humans
    2. Canela VH, Bowen WS, Ferreira RM, Syed F, Lingeman JE, Sabo AR, Barwinska D, Winfree S, Lake BB, Cheng YH, Gaut JP, Ferkowicz M, LaFavers KA, Zhang K, Coe FL, Worcester E, Kidney Precision Medicine Project, Jain S, Eadon MT, Williams JC, El-Achkar TM. A spatially anchored transcriptomic atlas of the human kidney papilla identifies significant immune injury in patients with stone disease. Nat Commun. 2023 07 19; 14(1):4140. PMID: 37468493; PMCID: PMC10356953.
      Citations: 3     Fields:    Translation:HumansCells
    3. LaFavers KA, Gaddy AR, Micanovic R, Lingeman J, Williams JC, Coe FL, El-Achkar TM, Worcester E. Water Loading and Uromodulin Secretion in Healthy Individuals and Idiopathic Calcium Stone Formers. Clin J Am Soc Nephrol. 2023 08 01; 18(8):1059-1067. PMID: 37256909; PMCID: PMC10564375.
      Citations: 2     Fields:    Translation:Humans
    4. Gutbrod J, Keys McKay CC, Coe L, Bergsland K, Coe F, Worcester E, Prochaska M. Clinical Effectiveness of Calcium Oxalate Stone Treatments. Am J Nephrol. 2022; 53(10):761-766. PMID: 36412567; PMCID: PMC9877156.
      Citations: 2     Fields:    Translation:Humans
    5. Bianco J, Chu F, Bergsland K, Coe F, Worcester E, Prochaska M. What treatments reduce kidney stone risk in patients with bowel disease? Urolithiasis. 2022 Oct; 50(5):557-565. PMID: 35976425; PMCID: PMC9972896.
      Citations:    Fields:    Translation:Humans
    6. Dhillon-Jhattu S, McGill RL, Ennis JL, Worcester EM, Zisman AL, Coe FL. Vitamin D and Parathyroid Hormone Levels in CKD. Am J Kidney Dis. 2023 01; 81(1):122-124. PMID: 35926776.
      Citations: 1     Fields:    Translation:Humans
    7. Williams JC, Al-Awadi H, Muthenini M, Bledsoe SB, El-Achkar T, Evan AP, Coe F, Lingeman JE, Worcester EM. Stone Morphology Distinguishes Two Pathways of Idiopathic Calcium Oxalate Stone Pathogenesis. J Endourol. 2022 05; 36(5):694-702. PMID: 34915736; PMCID: PMC9145590.
      Citations: 1     Fields:    Translation:Humans
    8. Betz MV, Coe FL, Chapman AB. Agreement of Food Records and 24-Hour Urine Studies in Clinical Practice. J Ren Nutr. 2022 01; 32(1):51-57. PMID: 34429244.
      Citations: 1     Fields:    Translation:Humans
    9. Prochaska ML, Moe OW, Coe FL, Worcester EM, Asplin JR. Evidence for abnormal linkage between urine oxalate and citrate excretion in human kidney stone formers. Physiol Rep. 2021 07; 9(13):e14943. PMID: 34231328; PMCID: PMC9814525.
      Citations: 2     Fields:    Translation:Humans
    10. Huo J, Li D, McKay C, Hoke M, Worcester E, Coe F. Relative contributions of urine sulfate, titratable urine anion, and GI anion to net acid load and effects of age. Physiol Rep. 2021 05; 9(10):e14870. PMID: 34042292; PMCID: PMC8157790.
      Citations: 2     Fields:    Translation:Humans
    11. Coe FL. Legends in Urology. Can J Urol. 2021 04; 28(2):10576-10579. PMID: 33872552.
      Citations:    Fields:    
    12. Bergsland KJ, Coe FL, El-Achkar TM, Worcester EM. Increased Urinary Leukocyte Esterase Distinguishes Patients With Brushite Kidney Stones. Kidney Int Rep. 2021 Jun; 6(6):1729-1731. PMID: 34169214; PMCID: PMC8207319.
      Citations:    
    13. Coe FL, Cohen AJ, Riedinger CB, Worcester EM, Zisman AL. Racial Differences in Risk Factors for Kidney Stone Formation. Clin J Am Soc Nephrol. 2020 08 07; 15(8):1166-1173. PMID: 32561654; PMCID: PMC7409744.
      Citations: 5     Fields:    Translation:Humans
    14. Makki MS, Winfree S, Lingeman JE, Witzmann FA, Worcester EM, Krambeck AE, Coe FL, Evan AP, Bledsoe S, Bergsland KJ, Khochare S, Barwinska D, Williams JC, El-Achkar TM. A Precision Medicine Approach Uncovers a Unique Signature of Neutrophils in Patients With Brushite Kidney Stones. Kidney Int Rep. 2020 May; 5(5):663-677. PMID: 32405588; PMCID: PMC7210605.
      Citations: 11     
    15. Evan AP, Coe FL, Worcester EM, Williams JC, Heiman J, Bledsoe S, Sommer A, Philips CL, Lingeman JE. Discrepancy Between Stone and Tissue Mineral Type in Patients with Idiopathic Uric Acid Stones. J Endourol. 2020 03; 34(3):385-393. PMID: 31880949; PMCID: PMC7099420.
      Citations: 1     Fields:    Translation:Humans
    16. Borofsky MS, Handa RK, Evan AP, Williams JC, Bledsoe S, Coe FL, Worcester EM, Lingeman JE. In Vivo Renal Tubule pH in Stone-Forming Human Kidneys. J Endourol. 2020 02; 34(2):203-208. PMID: 31760802; PMCID: PMC7047079.
      Citations: 2     Fields:    Translation:Humans
    17. Worcester EM, Bergsland KJ, Gillen DL, Coe FL. Evidence for disordered acid-base handling in calcium stone-forming patients. Am J Physiol Renal Physiol. 2020 02 01; 318(2):F363-F374. PMID: 31790303; PMCID: PMC7052659.
      Citations: 3     Fields:    Translation:HumansCells
    18. Ennis JL, Luo D, Asplin JR, Coe FL. A laboratory-based algorithm to predict future kidney function decline in older adults with reduced estimated glomerular filtration rate?. Clin Nephrol. 2019 Sep; 92(3):113-122. PMID: 31319905.
      Citations: 2     Fields:    Translation:Humans
    19. Menezes CJ, Worcester EM, Coe FL, Asplin J, Bergsland KJ, Ko B. Mechanisms for falling urine pH with age in stone formers. Am J Physiol Renal Physiol. 2019 07 01; 317(7):F65-F72. PMID: 31017011; PMCID: PMC6692718.
      Citations: 10     Fields:    Translation:Humans
    20. Boghosian ME, Hammes MS, Cassel KW, Akherat SMJ, Coe F. Restoration of wall shear stress in the cephalic vein during extreme hemodynamics. J Med Eng Technol. 2018 Nov; 42(8):617-627. PMID: 30942634; PMCID: PMC6714973.
      Citations: 3     Fields:    Translation:Humans
    21. Borofsky MS, Williams JC, Dauw CA, Cohen A, Evan AC, Coe FL, Worcester E, Lingeman JE. Association Between Randall's Plaque Stone Anchors and Renal Papillary Pits. J Endourol. 2019 04; 33(4):337-342. PMID: 30793930; PMCID: PMC6482910.
      Citations: 4     Fields:    Translation:Humans
    22. Evan AP, Coe FL, Lingeman J, Bledsoe S, Worcester EM. Randall's plaque in stone formers originates in ascending thin limbs. Am J Physiol Renal Physiol. 2018 11 01; 315(5):F1236-F1242. PMID: 30066583; PMCID: PMC6293286.
      Citations: 15     Fields:    Translation:Humans
    23. Bergsland KJ, Coe FL, Parks JH, Asplin JR, Worcester EM. Evidence for a role of PDZ domain-containing proteins to mediate hypophosphatemia in calcium stone formers. Nephrol Dial Transplant. 2018 05 01; 33(5):759-770. PMID: 29126251; PMCID: PMC6251596.
      Citations: 2     Fields:    Translation:HumansCells
    24. Worcester EM, Bergsland KJ, Gillen DL, Coe FL. Mechanism for higher urine pH in normal women compared with men. Am J Physiol Renal Physiol. 2018 04 01; 314(4):F623-F629. PMID: 29357436; PMCID: PMC5966764.
      Citations: 26     Fields:    Translation:Humans
    25. Williams JC, Borofsky MS, Bledsoe SB, Evan AP, Coe FL, Worcester EM, Lingeman JE. Papillary Ductal Plugging is a Mechanism for Early Stone Retention in Brushite Stone Disease. J Urol. 2018 01; 199(1):186-192. PMID: 28822796; PMCID: PMC5871923.
      Citations: 10     Fields:    Translation:Humans
    26. Javid Mahmoudzadeh Akherat SM, Cassel K, Boghosian M, Hammes M, Coe F. A Predictive Framework to Elucidate Venous Stenosis: CFD & Shape Optimization. Comput Methods Appl Mech Eng. 2017 Jul 01; 321:46-69. PMID: 28649146; PMCID: PMC5479643.
      Citations: 3     
    27. Cohen AJ, Borofsky MS, Anderson BB, Dauw CA, Gillen DL, Gerber GS, Worcester EM, Coe FL, Lingeman JE. Endoscopic Evidence That Randall's Plaque is Associated with Surface Erosion of the Renal Papilla. J Endourol. 2017 01; 31(1):85-90. PMID: 27824271; PMCID: PMC5220550.
      Citations: 4     Fields:    Translation:Humans
    28. Coe FL, Worcester EM, Evan AP. Idiopathic hypercalciuria and formation of calcium renal stones. Nat Rev Nephrol. 2016 09; 12(9):519-33. PMID: 27452364; PMCID: PMC5837277.
      Citations: 80     Fields:    Translation:Humans
    29. Gambaro G, Croppi E, Coe F, Lingeman J, Moe O, Worcester E, Buchholz N, Bushinsky D, Curhan GC, Ferraro PM, Fuster D, Goldfarb DS, Heilberg IP, Hess B, Lieske J, Marangella M, Milliner D, Preminger GM, Reis Santos JM, Sakhaee K, Sarica K, Siener R, Strazzullo P, Williams JC, Consensus Conference Group. Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement. J Nephrol. 2016 Dec; 29(6):715-734. PMID: 27456839; PMCID: PMC5080344.
      Citations: 76     Fields:    Translation:HumansCellsPHPublic Health
    30. Hammes M, Boghosian M, Cassel K, Watson S, Funaki B, Doshi T, Mahmoudzadeh Akherat SM, Hines J, Coe F. Increased Inlet Blood Flow Velocity Predicts Low Wall Shear Stress in the Cephalic Arch of Patients with Brachiocephalic Fistula Access. PLoS One. 2016; 11(4):e0152873. PMID: 27074019; PMCID: PMC4830603.
      Citations: 9     Fields:    Translation:Humans
    31. Witzmann FA, Evan AP, Coe FL, Worcester EM, Lingeman JE, Williams JC. Label-free proteomic methodology for the analysis of human kidney stone matrix composition. Proteome Sci. 2016; 14:4. PMID: 26924944; PMCID: PMC4769560.
      Citations: 16     
    32. Borofsky MS, Paonessa JE, Evan AP, Williams JC, Coe FL, Worcester EM, Lingeman JE. Introduction of a Renal Papillary Grading System for Patients with Nephrolithiasis. J Endourol B Videourol. 2015; 29(6). PMID: 32292640; PMCID: PMC6964239.
      Citations: 2     
    33. Gillen D, Rubenstein A, Worcester E, Coe F, Ennis J, Brecher ME, Asplin J. Clinical decision support improves physician guideline adherence for laboratory monitoring of chronic kidney disease: a matched cohort study. BMC Nephrol. 2015 Oct 15; 16:163. PMID: 26471846; PMCID: PMC4608162.
      Citations: 13     Fields:    Translation:Humans
    34. Borofsky MS, Paonessa JE, Evan AP, Williams JC, Coe FL, Worcester EM, Lingeman JE. A Proposed Grading System to Standardize the Description of Renal Papillary Appearance at the Time of Endoscopy in Patients with Nephrolithiasis. J Endourol. 2016 Jan; 30(1):122-7. PMID: 26414908; PMCID: PMC4744462.
      Citations: 15     Fields:    Translation:Humans
    35. Zisman AL, Evan AP, Coe FL, Worcester EM. Do kidney stone formers have a kidney disease? Kidney Int. 2015 Dec; 88(6):1240-1249. PMID: 26376133; PMCID: PMC4675687.
      Citations: 23     Fields:    
    36. Bhojani N, Paonessa JE, Hameed TA, Worcester EM, Evan AP, Coe FL, Borofsky MS, Lingeman JE. Nephrocalcinosis in Calcium Stone Formers Who Do Not have Systemic Disease. J Urol. 2015 Nov; 194(5):1308-12. PMID: 25988516; PMCID: PMC5774334.
      Citations: 4     Fields:    Translation:Humans
    37. Ko B, Bergsland K, Gillen DL, Evan AP, Clark DL, Baylock J, Coe FL, Worcester EM. Sex differences in proximal and distal nephron function contribute to the mechanism of idiopathic hypercalcuria in calcium stone formers. Am J Physiol Regul Integr Comp Physiol. 2015 Jul 01; 309(1):R85-92. PMID: 25947170; PMCID: PMC4491535.
      Citations: 8     Fields:    Translation:Humans
    38. Worcester EM, Coe FL, Sprague SM, Ennis JL. Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too low. J Nephrol. 2016 Feb; 29(1):63-70. PMID: 25736620.
      Citations: 14     Fields:    Translation:Humans
    39. Evan AP, Worcester EM, Williams JC, Sommer AJ, Lingeman JE, Phillips CL, Coe FL. Biopsy proven medullary sponge kidney: clinical findings, histopathology, and role of osteogenesis in stone and plaque formation. Anat Rec (Hoboken). 2015 May; 298(5):865-77. PMID: 25615853; PMCID: PMC4405475.
      Citations: 21     Fields:    Translation:Humans
    40. Evan AP, Coe FL, Connors BA, Handa RK, Lingeman JE, Worcester EM. Mechanism by which shock wave lithotripsy can promote formation of human calcium phosphate stones. Am J Physiol Renal Physiol. 2015 Apr 15; 308(8):F938-49. PMID: 25656372; PMCID: PMC4398833.
      Citations: 9     Fields:    Translation:HumansAnimals
    41. Evan AP, Worcester EM, Coe FL, Williams J, Lingeman JE. Mechanisms of human kidney stone formation. Urolithiasis. 2015 Jan; 43 Suppl 1:19-32. PMID: 25108546; PMCID: PMC4285570.
      Citations: 70     Fields:    Translation:Humans
    42. Williams JC, Lingeman JE, Coe FL, Worcester EM, Evan AP. Micro-CT imaging of Randall's plaques. Urolithiasis. 2015 Jan; 43 Suppl 1:13-7. PMID: 25096802; PMCID: PMC4285664.
      Citations: 14     Fields:    Translation:Humans
    43. Evan AP, Lingeman JE, Worcester EM, Sommer AJ, Phillips CL, Williams JC, Coe FL. Contrasting histopathology and crystal deposits in kidneys of idiopathic stone formers who produce hydroxy apatite, brushite, or calcium oxalate stones. Anat Rec (Hoboken). 2014 Apr; 297(4):731-48. PMID: 24478243; PMCID: PMC4014063.
      Citations: 34     Fields:    Translation:Humans
    44. Worcester EM, Evan AP, Coe FL, Lingeman JE, Krambeck A, Sommers A, Phillips CL, Milliner D. A test of the hypothesis that oxalate secretion produces proximal tubule crystallization in primary hyperoxaluria type I. Am J Physiol Renal Physiol. 2013 Dec 01; 305(11):F1574-84. PMID: 24089413; PMCID: PMC3882369.
      Citations: 24     Fields:    Translation:Humans
    45. Worcester EM, Bergsland KJ, Gillen DL, Coe FL. Evidence for increased renal tubule and parathyroid gland sensitivity to serum calcium in human idiopathic hypercalciuria. Am J Physiol Renal Physiol. 2013 Sep 15; 305(6):F853-60. PMID: 23863465; PMCID: PMC3761284.
      Citations: 9     Fields:    Translation:Humans
    46. Bergsland KJ, Worcester EM, Coe FL. Role of proximal tubule in the hypocalciuric response to thiazide of patients with idiopathic hypercalciuria. Am J Physiol Renal Physiol. 2013 Aug 15; 305(4):F592-9. PMID: 23720347; PMCID: PMC3891266.
      Citations: 18     Fields:    Translation:Humans
    47. Xu H, Zisman AL, Coe FL, Worcester EM. Kidney stones: an update on current pharmacological management and future directions. Expert Opin Pharmacother. 2013 Mar; 14(4):435-47. PMID: 23438422; PMCID: PMC3772648.
      Citations: 42     Fields:    Translation:HumansPHPublic Health
    48. Ennis J, Worcester E, Coe F. Contribution of calcium, phosphorus and 25-hydroxyvitamin D to the excessive severity of secondary hyperparathyroidism in African-Americans with CKD. Nephrol Dial Transplant. 2012 Jul; 27(7):2847-53. PMID: 22505656.
      Citations: 9     Fields:    Translation:Humans
    49. Bergsland KJ, Coe FL, White MD, Erhard MJ, DeFoor WR, Mahan JD, Schwaderer AL, Asplin JR. Urine risk factors in children with calcium kidney stones and their siblings. Kidney Int. 2012 Jun; 81(11):1140-8. PMID: 22358148; PMCID: PMC3353022.
      Citations: 9     Fields:    Translation:HumansCells
    50. Coe FL, Evan A, Worcester E. Pathophysiology-based treatment of idiopathic calcium kidney stones. Clin J Am Soc Nephrol. 2011 Aug; 6(8):2083-92. PMID: 21825103; PMCID: PMC5825183.
      Citations: 29     Fields:    Translation:HumansCellsPHPublic Health
    51. Coe FL. "A sudden lift of wings": Poetry and prose about Alzheimer's disease. Perspect Biol Med. 2011; 54(1):106-14. PMID: 21399388.
      Citations:    Fields:    Translation:Humans
    52. Bergsland KJ, Zisman AL, Asplin JR, Worcester EM, Coe FL. Evidence for net renal tubule oxalate secretion in patients with calcium kidney stones. Am J Physiol Renal Physiol. 2011 Feb; 300(2):F311-8. PMID: 21123489; PMCID: PMC3043999.
      Citations: 24     Fields:    Translation:Humans
    53. Evan AP, Weinman EJ, Wu XR, Lingeman JE, Worcester EM, Coe FL. Comparison of the pathology of interstitial plaque in human ICSF stone patients to NHERF-1 and THP-null mice. Urol Res. 2010 Dec; 38(6):439-52. PMID: 21063698; PMCID: PMC3035321.
      Citations: 15     Fields:    Translation:HumansAnimalsCells
    54. Miller NL, Humphreys MR, Coe FL, Evan AP, Bledsoe SB, Handa SE, Lingeman JE. Nephrocalcinosis: re-defined in the era of endourology. Urol Res. 2010 Dec; 38(6):421-7. PMID: 21057942; PMCID: PMC3787841.
      Citations: 9     Fields:    Translation:Humans
    55. Coe FL, Asplin JR. Medicine. Stopping the stones. Science. 2010 Oct 15; 330(6002):325-6. PMID: 20947749.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    56. Worcester EM, Coe FL. Clinical practice. Calcium kidney stones. N Engl J Med. 2010 Sep 02; 363(10):954-63. PMID: 20818905; PMCID: PMC3192488.
      Citations: 122     Fields:    Translation:Humans
    57. Coe FL. Stones. A matter of doubt--how best to evaluate stone formers. Nat Rev Urol. 2010 Sep; 7(9):483-5. PMID: 20818325.
      Citations:    Fields:    Translation:Humans
    58. Worcester EM, Coe FL. Evidence for altered renal tubule function in idiopathic calcium stone formers. Urol Res. 2010 Aug; 38(4):263-9. PMID: 20632168; PMCID: PMC3641150.
      Citations: 7     Fields:    Translation:HumansAnimals
    59. Coe FL, Evan AP, Lingeman JE, Worcester EM. Plaque and deposits in nine human stone diseases. Urol Res. 2010 Aug; 38(4):239-47. PMID: 20625890; PMCID: PMC3175811.
      Citations: 51     Fields:    Translation:Humans
    60. Evan AP, Lingeman JE, Worcester EM, Bledsoe SB, Sommer AJ, Williams JC, Krambeck AE, Philips CL, Coe FL. Renal histopathology and crystal deposits in patients with small bowel resection and calcium oxalate stone disease. Kidney Int. 2010 Aug; 78(3):310-7. PMID: 20428098; PMCID: PMC3787699.
      Citations: 38     Fields:    Translation:Humans
    61. Coe FL, Evan AP, Worcester EM, Lingeman JE. Three pathways for human kidney stone formation. Urol Res. 2010 Jun; 38(3):147-60. PMID: 20411383; PMCID: PMC3169174.
      Citations: 86     Fields:    Translation:Humans
    62. Kohn OF, Coe FL, Ing TS. Solute kinetics with short-daily home hemodialysis using slow dialysate flow rate. Hemodial Int. 2010 Jan; 14(1):39-46. PMID: 19758296.
      Citations: 10     Fields:    Translation:Humans
    63. Evan AP, Lingeman JE, Coe FL, Bledsoe SB, Sommer AJ, Williams JC, Krambeck AE, Worcester EM. Intra-tubular deposits, urine and stone composition are divergent in patients with ileostomy. Kidney Int. 2009 Nov; 76(10):1081-8. PMID: 19710630; PMCID: PMC3780771.
      Citations: 28     Fields:    Translation:Humans
    64. Bergsland KJ, Coe FL, Gillen DL, Worcester EM. A test of the hypothesis that the collecting duct calcium-sensing receptor limits rise of urine calcium molarity in hypercalciuric calcium kidney stone formers. Am J Physiol Renal Physiol. 2009 Oct; 297(4):F1017-23. PMID: 19640901; PMCID: PMC2775565.
      Citations: 20     Fields:    Translation:Humans
    65. Worcester EM, Coe FL. Does idiopathic hypercalciuria trigger calcium-sensing receptor-mediated protection from urinary supersaturation? J Am Soc Nephrol. 2009 Aug; 20(8):1657-9. PMID: 19578005.
      Citations: 2     Fields:    Translation:HumansAnimals
    66. Miller NL, Williams JC, Evan AP, Bledsoe SB, Coe FL, Worcester EM, Munch LC, Handa SE, Lingeman JE. In idiopathic calcium oxalate stone-formers, unattached stones show evidence of having originated as attached stones on Randall's plaque. BJU Int. 2010 Jan; 105(2):242-5. PMID: 19549258; PMCID: PMC2807918.
      Citations: 24     Fields:    Translation:Humans
    67. Hammes MS, Boghosian ME, Cassel KW, Funaki B, Coe FL. Characteristic differences in cephalic arch geometry for diabetic and non-diabetic ESRD patients. Nephrol Dial Transplant. 2009 Jul; 24(7):2190-4. PMID: 19244227.
      Citations: 11     Fields:    Translation:Humans
    68. Ennis J, Kocherginsky M, Schumm LP, Worcester E, Coe FL, Josephson MA. Trends in kidney donation among kidney stone formers: a survey of US transplant centers. Am J Nephrol. 2009; 30(1):12-8. PMID: 19169005.
      Citations: 7     Fields:    Translation:Humans
    69. Miller NL, Gillen DL, Williams JC, Evan AP, Bledsoe SB, Coe FL, Worcester EM, Matlaga BR, Munch LC, Lingeman JE. A formal test of the hypothesis that idiopathic calcium oxalate stones grow on Randall's plaque. BJU Int. 2009 Apr; 103(7):966-71. PMID: 19021625; PMCID: PMC3459677.
      Citations: 43     Fields:    Translation:Humans
    70. Parks JH, Coe FL. Evidence for durable kidney stone prevention over several decades. BJU Int. 2009 May; 103(9):1238-46. PMID: 19021617; PMCID: PMC2768493.
      Citations: 16     Fields:    Translation:HumansPHPublic Health
    71. Patel BN, Passman CM, Fernandez A, Asplin JR, Coe FL, Kim SC, Lingeman JE, Assimos DG. Prevalence of hyperoxaluria after bariatric surgery. J Urol. 2009 Jan; 181(1):161-6. PMID: 19013593; PMCID: PMC2637794.
      Citations: 32     Fields:    Translation:Humans
    72. Parks JH, Coe FL, Evan AP, Worcester EM. Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidism. BJU Int. 2009 Mar; 103(5):670-8. PMID: 18793297.
      Citations: 25     Fields:    Translation:Humans
    73. Worcester EM, Coe FL, Evan AP, Bergsland KJ, Parks JH, Willis LR, Clark DL, Gillen DL. Evidence for increased postprandial distal nephron calcium delivery in hypercalciuric stone-forming patients. Am J Physiol Renal Physiol. 2008 Nov; 295(5):F1286-94. PMID: 18715937; PMCID: PMC2584913.
      Citations: 37     Fields:    Translation:Humans
    74. Parks JH, Coe FL, Evan AP, Worcester EM. Urine pH in renal calcium stone formers who do and do not increase stone phosphate content with time. Nephrol Dial Transplant. 2009 Jan; 24(1):130-6. PMID: 18662977; PMCID: PMC2721421.
      Citations: 34     Fields:    Translation:Humans
    75. Worcester EM, Coe FL. Nephrolithiasis. Prim Care. 2008 Jun; 35(2):369-91, vii. PMID: 18486720; PMCID: PMC2518455.
      Citations: 66     Fields:    Translation:Humans
    76. Evan AE, Lingeman JE, Coe FL, Miller NL, Bledsoe SB, Sommer AJ, Williams JC, Shao Y, Worcester EM. Histopathology and surgical anatomy of patients with primary hyperparathyroidism and calcium phosphate stones. Kidney Int. 2008 Jul; 74(2):223-9. PMID: 18449170.
      Citations: 37     Fields:    Translation:Humans
    77. Evan AP, Coe FL, Gillen D, Lingeman JE, Bledsoe S, Worcester EM. Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones. Anat Rec (Hoboken). 2008 Mar; 291(3):325-34. PMID: 18286613.
      Citations: 26     Fields:    Translation:HumansCells
    78. Worcester EM, Coe FL. New insights into the pathogenesis of idiopathic hypercalciuria. Semin Nephrol. 2008 Mar; 28(2):120-32. PMID: 18359393; PMCID: PMC2362396.
      Citations: 62     Fields:    Translation:HumansAnimals
    79. Evan AP, Lingeman JE, Coe FL, Worcester EM. Role of interstitial apatite plaque in the pathogenesis of the common calcium oxalate stone. Semin Nephrol. 2008 Mar; 28(2):111-9. PMID: 18359392; PMCID: PMC2329574.
      Citations: 23     Fields:    Translation:Humans
    80. Hammes M, Funaki B, Coe FL. Cephalic arch stenosis in patients with fistula access for hemodialysis: relationship to diabetes and thrombosis. Hemodial Int. 2008 Jan; 12(1):85-9. PMID: 18271847.
      Citations: 18     Fields:    Translation:Humans
    81. Evan AP, Coe FL, Lingeman JE, Shao Y, Sommer AJ, Bledsoe SB, Anderson JC, Worcester EM. Mechanism of formation of human calcium oxalate renal stones on Randall's plaque. Anat Rec (Hoboken). 2007 Oct; 290(10):1315-23. PMID: 17724713.
      Citations: 87     Fields:    Translation:Humans
    82. Evan AP, Bledsoe S, Worcester EM, Coe FL, Lingeman JE, Bergsland KJ. Renal inter-alpha-trypsin inhibitor heavy chain 3 increases in calcium oxalate stone-forming patients. Kidney Int. 2007 Dec; 72(12):1503-11. PMID: 17898697.
      Citations: 23     Fields:    Translation:HumansCells
    83. Matlaga BR, Miller NL, Terry C, Kim SC, Kuo RL, Coe FL, Evan AP, Lingeman JE. The pathogenesis of calyceal diverticular calculi. Urol Res. 2007 Feb; 35(1):35-40. PMID: 17273836.
      Citations: 13     Fields:    Translation:Humans
    84. Asplin JR, Coe FL. Hyperoxaluria in kidney stone formers treated with modern bariatric surgery. J Urol. 2007 Feb; 177(2):565-9. PMID: 17222634.
      Citations: 55     Fields:    Translation:Humans
    85. Evan AP, Lingeman J, Coe F, Shao Y, Miller N, Matlaga B, Phillips C, Sommer A, Worcester E. Renal histopathology of stone-forming patients with distal renal tubular acidosis. Kidney Int. 2007 Apr; 71(8):795-801. PMID: 17264873.
      Citations: 49     Fields:    Translation:Humans
    86. Matlaga BR, Coe FL, Evan AP, Lingeman JE. The role of Randall's plaques in the pathogenesis of calcium stones. J Urol. 2007 Jan; 177(1):31-8. PMID: 17161996.
      Citations: 45     Fields:    Translation:Humans
    87. Worcester EM, Gillen DL, Evan AP, Parks JH, Wright K, Trumbore L, Nakagawa Y, Coe FL. Evidence that postprandial reduction of renal calcium reabsorption mediates hypercalciuria of patients with calcium nephrolithiasis. Am J Physiol Renal Physiol. 2007 Jan; 292(1):F66-75. PMID: 17210796.
      Citations: 35     Fields:    Translation:Humans
    88. Worcester E, Evan A, Bledsoe S, Lyon M, Chuang M, Orvieto M, Gerber G, Coe F. Pathophysiological correlates of two unique renal tubule lesions in rats with intestinal resection. Am J Physiol Renal Physiol. 2006 Nov; 291(5):F1061-9. PMID: 17028259.
      Citations: 3     Fields:    Translation:AnimalsCells
    89. Asplin JR, Donahue S, Kinder J, Coe FL. Urine calcium excretion predicts bone loss in idiopathic hypercalciuria. Kidney Int. 2006 Oct; 70(8):1463-7. PMID: 16941029.
      Citations: 30     Fields:    Translation:Humans
    90. Worcester EM, Parks JH, Evan AP, Coe FL. Renal function in patients with nephrolithiasis. J Urol. 2006 Aug; 176(2):600-3; discussion 603. PMID: 16813897.
      Citations: 38     Fields:    Translation:Humans
    91. Worcester EM, Coe FL, Evan AP, Parks JH. Reduced renal function and benefits of treatment in cystinuria vs other forms of nephrolithiasis. BJU Int. 2006 Jun; 97(6):1285-90. PMID: 16686727.
      Citations: 23     Fields:    Translation:Humans
    92. Evan AP, Coe FL, Lingeman JE, Shao Y, Matlaga BR, Kim SC, Bledsoe SB, Sommer AJ, Grynpas M, Phillips CL, Worcester EM. Renal crystal deposits and histopathology in patients with cystine stones. Kidney Int. 2006 Jun; 69(12):2227-35. PMID: 16710357.
      Citations: 57     Fields:    Translation:HumansCells
    93. Matlaga BR, Williams JC, Kim SC, Kuo RL, Evan AP, Bledsoe SB, Coe FL, Worcester EM, Munch LC, Lingeman JE. Endoscopic evidence of calculus attachment to Randall's plaque. J Urol. 2006 May; 175(5):1720-4; discussion 1724. PMID: 16600740.
      Citations: 32     Fields:    Translation:Humans
    94. Bergsland KJ, Kelly JK, Coe BJ, Coe FL. Urine protein markers distinguish stone-forming from non-stone-forming relatives of calcium stone formers. Am J Physiol Renal Physiol. 2006 Sep; 291(3):F530-6. PMID: 16622176.
      Citations: 14     Fields:    Translation:HumansCells
    95. Evan A, Lingeman J, Coe FL, Worcester E. Randall's plaque: pathogenesis and role in calcium oxalate nephrolithiasis. Kidney Int. 2006 Apr; 69(8):1313-8. PMID: 16614720.
      Citations: 97     Fields:    Translation:Humans
    96. Goldfarb DS, Coe FL, Asplin JR. Urinary cystine excretion and capacity in patients with cystinuria. Kidney Int. 2006 Mar; 69(6):1041-7. PMID: 16501494.
      Citations: 29     Fields:    Translation:HumansCells
    97. Stankus N, Worcester E, Hammes M, Coe FL. Evidence against a contribution of conventional urine risk factors to de novo ESRD renal stones. Nephrol Dial Transplant. 2006 Mar; 21(3):701-6. PMID: 16326738.
      Citations: 1     Fields:    Translation:Humans
    98. Worcester EM, Chuang M, Laven B, Orvieto M, Coe FL, Evan AP, Gerber GS. A new animal model of hyperoxaluria and nephrolithiasis in rats with small bowel resection. Urol Res. 2005 Nov; 33(5):380-2. PMID: 16284881.
      Citations: 2     Fields:    Translation:Animals
    99. Coe FL, Evan A, Worcester E. Kidney stone disease. J Clin Invest. 2005 Oct; 115(10):2598-608. PMID: 16200192; PMCID: PMC1236703.
      Citations: 222     Fields:    Translation:HumansAnimals
    100. Evan AP, Coe FL, Lingeman JE, Worcester E. Insights on the pathology of kidney stone formation. Urol Res. 2005 Nov; 33(5):383-9. PMID: 16078085.
      Citations: 20     Fields:    Translation:Humans
    101. Gillen DL, Coe FL, Worcester EM. Nephrolithiasis and increased blood pressure among females with high body mass index. Am J Kidney Dis. 2005 Aug; 46(2):263-9. PMID: 16112044.
      Citations: 25     Fields:    Translation:Humans
    102. Evan AP, Coe FL, Rittling SR, Bledsoe SM, Shao Y, Lingeman JE, Worcester EM. Apatite plaque particles in inner medulla of kidneys of calcium oxalate stone formers: osteopontin localization. Kidney Int. 2005 Jul; 68(1):145-54. PMID: 15954903.
      Citations: 52     Fields:    Translation:Humans
    103. O'Connor RC, Worcester EM, Evan AP, Meehan S, Kuznetsov D, Laven B, Sommer AJ, Bledsoe SB, Parks JH, Coe FL, Grynpas M, Gerber GS. Nephrolithiasis and nephrocalcinosis in rats with small bowel resection. Urol Res. 2005 May; 33(2):105-15. PMID: 15815943.
      Citations: 11     Fields:    Translation:Animals
    104. Evan AP, Lingeman JE, Coe FL, Shao Y, Parks JH, Bledsoe SB, Phillips CL, Bonsib S, Worcester EM, Sommer AJ, Kim SC, Tinmouth WW, Grynpas M. Crystal-associated nephropathy in patients with brushite nephrolithiasis. Kidney Int. 2005 Feb; 67(2):576-91. PMID: 15673305.
      Citations: 82     Fields:    Translation:HumansCells
    105. Gillen DL, Worcester EM, Coe FL. Decreased renal function among adults with a history of nephrolithiasis: a study of NHANES III. Kidney Int. 2005 Feb; 67(2):685-90. PMID: 15673317.
      Citations: 50     Fields:    Translation:Humans
    106. Kim SC, Coe FL, Tinmouth WW, Kuo RL, Paterson RF, Parks JH, Munch LC, Evan AP, Lingeman JE. Stone formation is proportional to papillary surface coverage by Randall's plaque. J Urol. 2005 Jan; 173(1):117-9; discussion 119. PMID: 15592050.
      Citations: 42     Fields:    Translation:Humans
    107. Pramanik R, Asplin JR, Lindeman C, Favus MJ, Bai S, Coe FL. Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells. Cell Immunol. 2004 Nov-Dec; 232(1-2):137-43. PMID: 15876428.
      Citations: 15     Fields:    Translation:HumansCells
    108. Favus MJ, Karnauskas AJ, Parks JH, Coe FL. Peripheral blood monocyte vitamin D receptor levels are elevated in patients with idiopathic hypercalciuria. J Clin Endocrinol Metab. 2004 Oct; 89(10):4937-43. PMID: 15472188.
      Citations: 33     Fields:    Translation:HumansCells
    109. Parks JH, Worcester EM, Coe FL, Evan AP, Lingeman JE. Clinical implications of abundant calcium phosphate in routinely analyzed kidney stones. Kidney Int. 2004 Aug; 66(2):777-85. PMID: 15253733.
      Citations: 80     Fields:    Translation:Humans
    110. Kuo RL, Lingeman JE, Evan AP, Paterson RF, Parks JH, Bledsoe SB, Munch LC, Coe FL. Urine calcium and volume predict coverage of renal papilla by Randall's plaque. Kidney Int. 2003 Dec; 64(6):2150-4. PMID: 14633137.
      Citations: 74     Fields:    Translation:Humans
    111. Worcester E, Parks JH, Josephson MA, Thisted RA, Coe FL. Causes and consequences of kidney loss in patients with nephrolithiasis. Kidney Int. 2003 Dec; 64(6):2204-13. PMID: 14633144.
      Citations: 34     Fields:    Translation:Humans
    112. Kuo RL, Lingeman JE, Evan AP, Paterson RF, Bledsoe SB, Kim SC, Munch LC, Coe FL. Endoscopic renal papillary biopsies: a tissue retrieval technique for histological studies in patients with nephrolithiasis. J Urol. 2003 Dec; 170(6 Pt 1):2186-9. PMID: 14634375.
      Citations: 9     Fields:    Translation:Humans
    113. Evan AP, Lingeman JE, Coe FL, Parks JH, Bledsoe SB, Shao Y, Sommer AJ, Paterson RF, Kuo RL, Grynpas M. Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest. 2003 Mar; 111(5):607-16. PMID: 12618515; PMCID: PMC151900.
      Citations: 227     Fields:    Translation:HumansCells
    114. Asplin JR, Bauer KA, Kinder J, Coe BJ, Parks JH, Coe FL, Müller G. Bone mineral density and urine calcium excretion among subjects with and without nephrolithiasis. Kidney Int. 2003 Feb; 63(2):662-9. PMID: 12631132.
      Citations: 44     Fields:    Translation:Humans
    115. Coe FL. Editorial: Something new about stones. J Urol. 2003 Feb; 169(2):478-9. PMID: 12544291.
      Citations: 1     Fields:    Translation:Humans
    116. Parks JH, Worcester EM, O'Connor RC, Coe FL. Urine stone risk factors in nephrolithiasis patients with and without bowel disease. Kidney Int. 2003 Jan; 63(1):255-65. PMID: 12472791.
      Citations: 38     Fields:    Translation:Humans
    117. Bergsland KJ, Kinder JM, Asplin JR, Coe BJ, Coe FL. Influence of gender and age on calcium oxalate crystal growth inhibition by urine from relatives of stone forming patients. J Urol. 2002 Jun; 167(6):2372-6. PMID: 11992040.
      Citations: 11     Fields:    Translation:HumansCells
    118. Asplin JR, Parks JH, Nakagawa Y, Coe FL, Asplin JR, Parks JH, Nakagawa Y, Coe FL. Reduced crystallization inhibition by urine from women with nephrolithiasis. Kidney Int. 2002 May; 61(5):1821-9. PMID: 11967033.
      Citations: 12     Fields:    Translation:AnimalsCells
    119. Kinder JM, Clark CD, Coe BJ, Asplin JR, Parks JH, Coe FL, Kinder JM, Clark CD, Coe BJ, Asplin JR, Parks JH, Coe FL. Urinary stone risk factors in the siblings of patients with calcium renal stones. J Urol. 2002 May; 167(5):1965-7. PMID: 11956418.
      Citations: 2     Fields:    Translation:Humans
    120. Coe FL, Parks JH, Coe FL, Parks JH. Does a failure of crystal inhibition cause calcium renal stones? Nephron. 2002 Apr; 90(4):361-4. PMID: 11961392.
      Citations:    Fields:    Translation:HumansCells
    121. Parks JH, Goldfisher E, Asplin JR, Coe FL. A single 24-hour urine collection is inadequate for the medical evaluation of nephrolithiasis. J Urol. 2002 Apr; 167(4):1607-12. PMID: 11912373.
      Citations: 49     Fields:    Translation:Humans
    122. Bushinsky DA, Asplin JR, Grynpas MD, Evan AP, Parker WR, Alexander KM, Coe FL, Bushinsky DA, Asplin JR, Grynpas MD, Evan AP, Parker WR, Alexander KM, Coe FL. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats. Kidney Int. 2002 Mar; 61(3):975-87. PMID: 11849452.
      Citations: 42     Fields:    Translation:Animals
    123. Parks JH, Asplin JR, Coe FL. Patient adherence to long-term medical treatment of kidney stones. J Urol. 2001 Dec; 166(6):2057-60. PMID: 11696706.
      Citations: 16     Fields:    Translation:Humans
    124. Coe FL, Wise H, Parks JH, Asplin JR. Proportional reduction of urine supersaturation during nephrolithiasis treatment. J Urol. 2001 Oct; 166(4):1247-51. PMID: 11547051.
      Citations: 4     Fields:    Translation:Humans
    125. Coe FL, Clark C, Parks JH, Asplin JR. Solid phase assay of urine cystine supersaturation in the presence of cystine binding drugs. J Urol. 2001 Aug; 166(2):688-93. PMID: 11458118.
      Citations: 16     Fields:    Translation:HumansCells
    126. Coe FL, Wise H, Parks JH, Fleury PJ, Asplin JR. Differences in urine volume and supersaturation in 2 physician networks. J Urol. 2001 Aug; 166(2):423-8. PMID: 11458041.
      Citations:    Fields:    Translation:Humans
    127. Nakagawa Y, Asplin JR, Goldfarb DS, Parks JH, Coe FL. Clinical use of cystine supersaturation measurements. J Urol. 2000 Nov; 164(5):1481-5. PMID: 11025687.
      Citations: 28     Fields:    Translation:Humans
    128. Goldfarb DS, Coe FL. Prevention of recurrent nephrolithiasis. Am Fam Physician. 1999 Nov 15; 60(8):2269-76. PMID: 10593318.
      Citations: 9     Fields:    Translation:Humans
    129. Nakagawa Y, Coe FL. A modified cyanide-nitroprusside method for quantifying urinary cystine concentration that corrects for creatinine interference. Clin Chim Acta. 1999 Nov; 289(1-2):57-68. PMID: 10556653.
      Citations: 7     Fields:    Translation:Humans
    130. Shahinfar S, Simpson RL, Carides AD, Thiyagarajan B, Nakagawa Y, Umans JG, Parks JH, Coe FL. Safety of losartan in hypertensive patients with thiazide-induced hyperuricemia. Kidney Int. 1999 Nov; 56(5):1879-85. PMID: 10571797.
      Citations: 19     Fields:    Translation:HumansCTClinical Trials
    131. Asplin JR, Parks JH, Chen MS, Lieske JC, Toback FG, Pillay SN, Nakagawa Y, Coe FL. Reduced crystallization inhibition by urine from men with nephrolithiasis. Kidney Int. 1999 Oct; 56(4):1505-16. PMID: 10504502.
      Citations: 14     Fields:    Translation:HumansCells
    132. Lingeman J, Kahnoski R, Mardis H, Goldfarb DS, Grasso M, Lacy S, Scheinman SJ, Asplin JR, Parks JH, Coe FL. Divergence between stone composition and urine supersaturation: clinical and laboratory implications. J Urol. 1999 Apr; 161(4):1077-81. PMID: 10081841.
      Citations: 7     Fields:    Translation:HumansCells
    133. Bushinsky DA, Bashir MA, Riordon DR, Nakagawa Y, Coe FL, Grynpas MD. Increased dietary oxalate does not increase urinary calcium oxalate saturation in hypercalciuric rats. Kidney Int. 1999 Feb; 55(2):602-12. PMID: 9987084.
      Citations: 13     Fields:    Translation:Animals
    134. Goldfarb DS, Coe FL. Beverages, diet, and prevention of kidney stones. Am J Kidney Dis. 1999 Feb; 33(2):398-400; discussion 401-3. PMID: 10023657.
      Citations: 5     Fields:    Translation:HumansAnimals
    135. Lingeman J, Mardis H, Kahnoski R, Goldfarb DS, Lacy S, Grasso M, Scheinman SJ, Parks JH, Asplin JR, Coe FL. Medical reduction of stone risk in a network of treatment centers compared to a research clinic. J Urol. 1998 Nov; 160(5):1629-34. PMID: 9783920.
      Citations: 12     Fields:    Translation:Humans
    136. Goldfarb DS, Coe FL. Foscarnet crystal deposition and renal failure. Am J Kidney Dis. 1998 Sep; 32(3):519-20. PMID: 9740173.
      Citations: 3     Fields:    Translation:HumansCells
    137. Pillay SN, Asplin JR, Coe FL. Evidence that calgranulin is produced by kidney cells and is an inhibitor of calcium oxalate crystallization. Am J Physiol. 1998 08; 275(2):F255-61. PMID: 9691016.
      Citations: 17     Fields:    Translation:HumansAnimalsCells
    138. Asplin J, Parks J, Lingeman J, Kahnoski R, Mardis H, Lacey S, Goldfarb D, Grasso M, Coe F. Supersaturation and stone composition in a network of dispersed treatment sites. J Urol. 1998 Jun; 159(6):1821-5. PMID: 9598467.
      Citations: 17     Fields:    Translation:HumansCells
    139. Goldfarb DS, Parks JH, Coe FL. Renal stone disease in older adults. Clin Geriatr Med. 1998 May; 14(2):367-81. PMID: 9536110.
      Citations: 6     Fields:    Translation:Humans
    140. Asplin JR, Lingeman J, Kahnoski R, Mardis H, Parks JH, Coe FL. Metabolic urinary correlates of calcium oxalate dihydrate in renal stones. J Urol. 1998 Mar; 159(3):664-8. PMID: 9474121.
      Citations: 12     Fields:    Translation:Humans
    141. Asplin JR, Arsenault D, Parks JH, Coe FL, Hoyer JR. Contribution of human uropontin to inhibition of calcium oxalate crystallization. Kidney Int. 1998 Jan; 53(1):194-9. PMID: 9453018.
      Citations: 22     Fields:    Translation:HumansCells
    142. Asplin JR, Parks JH, Coe FL. Dependence of upper limit of metastability on supersaturation in nephrolithiasis. Kidney Int. 1997 Dec; 52(6):1602-8. PMID: 9407506.
      Citations: 17     Fields:    Translation:HumansCells
    143. Coe FL, Parks JH, Favus MJ. Diet and calcium: the end of an era? Ann Intern Med. 1997 Apr 01; 126(7):553-5. PMID: 9092322.
      Citations: 1     Fields:    Translation:Humans
    144. Coe FL, Parks JH. New insights into the pathophysiology and treatment of nephrolithiasis: new research venues. J Bone Miner Res. 1997 Apr; 12(4):522-33. PMID: 9101363.
      Citations: 6     Fields:    Translation:HumansAnimals
    145. Parks JH, Coward M, Coe FL. Correspondence between stone composition and urine supersaturation in nephrolithiasis. Kidney Int. 1997 Mar; 51(3):894-900. PMID: 9067927.
      Citations: 64     Fields:    Translation:HumansCells
    146. Asplin JR, Bushinsky DA, Singharetnam W, Riordon D, Parks JH, Coe FL. Relationship between supersaturation and crystal inhibition in hypercalciuric rats. Kidney Int. 1997 Mar; 51(3):640-5. PMID: 9067894.
      Citations: 14     Fields:    Translation:AnimalsCells
    147. Coe FL. "Felix Randal": a poem about medicine. Pharos Alpha Omega Alpha Honor Med Soc. 1997; 60(2):24-8. PMID: 9197141.
      Citations:    Fields:    Translation:Humans
    148. Parks JH, Coe FL. The financial effects of kidney stone prevention. Kidney Int. 1996 Nov; 50(5):1706-12. PMID: 8914040.
      Citations: 22     Fields:    Translation:HumansCTClinical Trials
    149. Parks JH, Coe FL. Pathogenesis and treatment of calcium stones. Semin Nephrol. 1996 Sep; 16(5):398-411. PMID: 8890396.
      Citations: 3     Fields:    Translation:Humans
    150. Porile JL, Asplin JR, Parks JH, Nakagawa Y, Coe FL. Normal calcium oxalate crystal growth inhibition in severe calcium oxalate nephrolithiasis. J Am Soc Nephrol. 1996 Apr; 7(4):602-7. PMID: 8724894.
      Citations: 2     Fields:    Translation:HumansCells
    151. Asplin JR, Mandel NS, Coe FL. Evidence of calcium phosphate supersaturation in the loop of Henle. Am J Physiol. 1996 Apr; 270(4 Pt 2):F604-13. PMID: 8967338.
      Citations: 40     Fields:    Translation:AnimalsCells
    152. Bushinsky DA, Grynpas MD, Nilsson EL, Nakagawa Y, Coe FL. Stone formation in genetic hypercalciuric rats. Kidney Int. 1995 Dec; 48(6):1705-13. PMID: 8587230.
      Citations: 27     Fields:    Translation:Animals
    153. Coe FL, Parks JH. Idiopathic hypercalciuria: the contribution of Dr. Jacob Lemann, Jr. J Am Soc Nephrol. 1994 Nov; 5(5 Suppl 1):S59-69. PMID: 7873747.
      Citations: 2     Fields:    Translation:Humans
    154. Parks JH, Coe FL. An increasing number of calcium oxalate stone events worsens treatment outcome. Kidney Int. 1994 Jun; 45(6):1722-30. PMID: 7933820.
      Citations: 11     Fields:    Translation:Humans
    155. Coe FL. Calcium restriction, thiazide, citrate, and allopurinol in calcium oxalate nephrolithiasis. Acta Urol Belg. 1994 Jun; 62(2):25-9. PMID: 8037000.
      Citations:    Fields:    Translation:Humans
    156. Worcester EM, Fellner SK, Nakagawa Y, Coe FL. Effect of renal transplantation on serum oxalate and urinary oxalate excretion. Nephron. 1994; 67(4):414-8. PMID: 7969673.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    157. Bushinsky DA, Kim M, Sessler NE, Nakagawa Y, Coe FL. Increased urinary saturation and kidney calcium content in genetic hypercalciuric rats. Kidney Int. 1994 Jan; 45(1):58-65. PMID: 8127022.
      Citations: 13     Fields:    Translation:Animals
    158. Coe FL, Nakagawa Y, Asplin J, Parks JH. Role of nephrocalcin in inhibition of calcium oxalate crystallization and nephrolithiasis. Miner Electrolyte Metab. 1994; 20(6):378-84. PMID: 7783700.
      Citations: 8     Fields:    Translation:HumansAnimalsCells
    159. Coe FL, Parks JH, Asplin JR. The pathogenesis and treatment of kidney stones. N Engl J Med. 1992 Oct 15; 327(16):1141-52. PMID: 1528210.
      Citations: 154     Fields:    Translation:Humans
    160. Nakagawa Y, Sirivongs D, Novy MB, Netzer MF, Michaels E, Vogelzang NJ, Coe FL. Nephrocalcin: biosynthesis by human renal carcinoma cells in vitro and in vivo. Cancer Res. 1992 Mar 15; 52(6):1573-9. PMID: 1540966.
      Citations: 2     Fields:    Translation:HumansCells
    161. Coe FL, Parks JH, Webb DR. Stone-forming potential of milk or calcium-fortified orange juice in idiopathic hypercalciuric adults. Kidney Int. 1992 Jan; 41(1):139-42. PMID: 1593849.
      Citations: 2     Fields:    Translation:HumansAnimalsCTClinical Trials
    162. Asplin J, DeGanello S, Nakagawa YN, Coe FL. Evidence that nephrocalcin and urine inhibit nucleation of calcium oxalate monohydrate crystals. Am J Physiol. 1991 Nov; 261(5 Pt 2):F824-30. PMID: 1951713.
      Citations: 4     Fields:    Translation:HumansCells
    163. Hess B, Nakagawa Y, Parks JH, Coe FL. Molecular abnormality of Tamm-Horsfall glycoprotein in calcium oxalate nephrolithiasis. Am J Physiol. 1991 Apr; 260(4 Pt 2):F569-78. PMID: 2012207.
      Citations: 18     Fields:    Translation:HumansCells
    164. Coe FL, Nakagawa Y, Parks JH. Inhibitors within the nephron. Am J Kidney Dis. 1991 Apr; 17(4):407-13. PMID: 2008908.
      Citations: 9     Fields:    Translation:HumansAnimalsCells
    165. Nakagawa Y, Renz CL, Ahmed M, Coe FL. Isolation of nephrocalcin from kidney tissue of nine vertebrate species. Am J Physiol. 1991 Feb; 260(2 Pt 2):F243-8. PMID: 1996674.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    166. Coe FL, Parks JH. Hereditary aspects of calcium nephrolithiasis. Adv Nephrol Necker Hosp. 1991; 20:31-40. PMID: 2063720.
      Citations:    Fields:    Translation:HumansAnimals
    167. Coe F, Parks JH. Defenses of an unstable compromise: crystallization inhibitors and the kidney's role in mineral regulation. Kidney Int. 1990 Oct; 38(4):625-31. PMID: 2232503.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    168. Sirivongs D, Nakagawa Y, Vishny WK, Favus MJ, Coe FL. Evidence that mouse renal proximal tubule cells produce nephrocalcin. Am J Physiol. 1989 Sep; 257(3 Pt 2):F390-8. PMID: 2782421.
      Citations:    Fields:    Translation:AnimalsCells
    169. Nakagawa Y, Otsuki T, Coe FL. Elucidation of multiple forms of nephrocalcin by 31P-NMR spectrometer. FEBS Lett. 1989 Jul 03; 250(2):187-90. PMID: 2753126.
      Citations: 2     Fields:    Translation:Animals
    170. Hess B, Nakagawa Y, Coe FL. Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins. Am J Physiol. 1989 Jul; 257(1 Pt 2):F99-106. PMID: 2750929.
      Citations: 60     Fields:    Translation:HumansCells
    171. Maikranz P, Holley JL, Parks JH, Lindheimer MD, Nakagawa Y, Coe FL. Gestational hypercalciuria causes pathological urine calcium oxalate supersaturations. Kidney Int. 1989 Jul; 36(1):108-13. PMID: 2811052.
      Citations: 17     Fields:    Translation:Humans
    172. Coe FL, Hess B. A new spectrophotometric method for measuring calcium oxalate monohydrate crystal aggregation in the absence of supersaturation: inhibitory effects of urinary glycoproteins. Urol Res. 1989; 17(3):149-50. PMID: 2749944.
      Citations: 2     Fields:    Translation:HumansCells
    173. Coe FL, Parks JH. The risks of oral contraceptives and estrogen replacement therapy. Perspect Biol Med. 1989; 33(1):86-106. PMID: 2689999.
      Citations: 1     Fields:    Translation:Humans
    174. Worcester EM, Nakagawa Y, Wabner CL, Kumar S, Coe FL. Crystal adsorption and growth slowing by nephrocalcin, albumin, and Tamm-Horsfall protein. Am J Physiol. 1988 Dec; 255(6 Pt 2):F1197-205. PMID: 3202183.
      Citations: 21     Fields:    Translation:HumansCells
    175. Coe FL, Parks JH, Bushinsky DA, Langman CB, Favus MJ. Chlorthalidone promotes mineral retention in patients with idiopathic hypercalciuria. Kidney Int. 1988 Jun; 33(6):1140-6. PMID: 3404813.
      Citations: 20     Fields:    Translation:HumansCTClinical Trials
    176. Coe FL, Parks JH. Pathophysiology of kidney stones and strategies for treatment. Hosp Pract (Off Ed). 1988 Mar 15; 23(3):185-9, 193-5, 199-200 passim. PMID: 3126203.
      Citations: 5     Fields:    Translation:Humans
    177. Maikranz P, Coe FL, Parks JH, Lindheimer MD. Nephrolithiasis and gestation. Baillieres Clin Obstet Gynaecol. 1987 Dec; 1(4):909-19. PMID: 3330492.
      Citations: 8     Fields:    Translation:Humans
    178. Kristensen C, Parks JH, Lindheimer M, Coe FL. Reduced glomerular filtration rate and hypercalciuria in primary struvite nephrolithiasis. Kidney Int. 1987 Nov; 32(5):749-53. PMID: 3430961.
      Citations: 9     Fields:    Translation:Humans
    179. Nakagawa Y, Ahmed M, Hall SL, Deganello S, Coe FL. Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in gamma-carboxyglutamic acid. J Clin Invest. 1987 Jun; 79(6):1782-7. PMID: 3584470; PMCID: PMC424521.
      Citations: 30     Fields:    Translation:HumansCells
    180. Maikranz P, Coe FL, Parks J, Lindheimer MD. Nephrolithiasis in pregnancy. Am J Kidney Dis. 1987 Apr; 9(4):354-8. PMID: 3555009.
      Citations: 6     Fields:    Translation:Humans
    181. Worcester EM, Nakagawa Y, Coe FL. Glycoprotein calcium oxalate crystal growth inhibitor in urine. Miner Electrolyte Metab. 1987; 13(4):267-72. PMID: 3306319.
      Citations: 7     Fields:    Translation:Humans
    182. Favus MJ, Bushinsky DA, Coe FL. Effects of medium pH on duodenal and ileal calcium active transport in the rat. Am J Physiol. 1986 Nov; 251(5 Pt 1):G695-700. PMID: 3096149.
      Citations: 2     Fields:    Translation:Animals
    183. Langman CB, Bushinsky DA, Favus MJ, Coe FL. Ca and P regulation of 1,25(OH)2D3 synthesis by vitamin D-replete rat tubules during acidosis. Am J Physiol. 1986 Nov; 251(5 Pt 2):F911-8. PMID: 3777187.
      Citations: 2     Fields:    Translation:Animals
    184. Edington HD, Hancock S, Coe FL, Sugarbaker PH. Preliminary report of a new treatment strategy for advanced pelvic malignancy: surgical resection and radiation therapy using afterloading catheters plus an inflatable displacement prosthesis in the treatment of advanced primary and recurrent rectal cancer. Surgery. 1986 Sep; 100(3):494-9. PMID: 3738769.
      Citations: 1     Fields:    Translation:Humans
    185. Parks JH, Coe FL. A urinary calcium-citrate index for the evaluation of nephrolithiasis. Kidney Int. 1986 Jul; 30(1):85-90. PMID: 3747347.
      Citations: 30     Fields:    Translation:Humans
    186. Bushinsky DA, Favus MJ, Langman CB, Coe FL. Mechanism of chronic hypercalciuria with furosemide: increased calcium absorption. Am J Physiol. 1986 Jul; 251(1 Pt 2):F17-24. PMID: 3755294.
      Citations: 5     Fields:    Translation:Animals
    187. Coe FL, Favus MJ, Parks JH. Is estrogen preferable to surgery for postmenopausal women with primary hyperparathyroidism? N Engl J Med. 1986 Jun 05; 314(23):1508-9. PMID: 3702965.
      Citations: 1     Fields:    Translation:Humans
    188. Worcester EM, Nakagawa Y, Bushinsky DA, Coe FL. Evidence that serum calcium oxalate supersaturation is a consequence of oxalate retention in patients with chronic renal failure. J Clin Invest. 1986 Jun; 77(6):1888-96. PMID: 3711339; PMCID: PMC370548.
      Citations: 13     Fields:    Translation:Humans
    189. Bushinsky DA, Levi-Setti R, Coe FL. Ion microprobe determination of bone surface elements: effects of reduced medium pH. Am J Physiol. 1986 Jun; 250(6 Pt 2):F1090-7. PMID: 3717349.
      Citations: 5     Fields:    Translation:Animals
    190. Lopez M, Nakagawa Y, Coe FL, Tsai C, Michael AF, Scheinman JI. Immunochemistry of urinary calcium oxalate crystal growth inhibitor (CGI). Kidney Int. 1986 Apr; 29(4):829-33. PMID: 3520093.
      Citations: 2     Fields:    Translation:Humans
    191. Kristensen CG, Nakagawa Y, Coe FL, Lindheimer MD. Effect of atrial natriuretic factor in rat pregnancy. Am J Physiol. 1986 Apr; 250(4 Pt 2):R589-94. PMID: 2938487.
      Citations: 6     Fields:    Translation:AnimalsCells
    192. Coe FL, Parks JH. Recurrent renal calculi. Causes and prevention. Hosp Pract (Off Ed). 1986 Mar 30; 21(3A):49-57. PMID: 3081562.
      Citations:    Fields:    Translation:Humans
    193. Parks JH, Coe FL. Urine citrate and calcium in calcium nephrolithiasis. Adv Exp Med Biol. 1986; 208:445-9. PMID: 3565157.
      Citations:    Fields:    Translation:Humans
    194. Bushinsky DA, Riera GS, Favus MJ, Coe FL. Evidence that blood ionized calcium can regulate serum 1,25(OH)2D3 independently of parathyroid hormone and phosphorus in the rat. J Clin Invest. 1985 Oct; 76(4):1599-604. PMID: 3840495; PMCID: PMC424140.
      Citations: 10     Fields:    Translation:Animals
    195. Nakagawa Y, Abram V, Parks JH, Lau HS, Kawooya JK, Coe FL. Urine glycoprotein crystal growth inhibitors. Evidence for a molecular abnormality in calcium oxalate nephrolithiasis. J Clin Invest. 1985 Oct; 76(4):1455-62. PMID: 4056037; PMCID: PMC424101.
      Citations: 22     Fields:    Translation:HumansCells
    196. Langman CB, Favus MJ, Bushinsky DA, Coe FL. Effects of dietary calcium restriction on 1,25-dihydroxyvitamin D3 net synthesis by rat proximal tubules. J Lab Clin Med. 1985 Sep; 106(3):286-92. PMID: 2993458.
      Citations: 2     Fields:    Translation:Animals
    197. Bushinsky DA, Riera GS, Favus MJ, Coe FL. Response of serum 1,25(OH)2D3 to variation of ionized calcium during chronic acidosis. Am J Physiol. 1985 Sep; 249(3 Pt 2):F361-5. PMID: 2994493.
      Citations: 8     Fields:    Translation:Animals
    198. Bushinsky DA, Goldring JM, Coe FL. Cellular contribution to pH-mediated calcium flux in neonatal mouse calvariae. Am J Physiol. 1985 Jun; 248(6 Pt 2):F785-9. PMID: 3839112.
      Citations: 9     Fields:    Translation:AnimalsCells
    199. Moore ES, Langman CB, Favus MJ, Coe FL. Role of fetal 1,25-dihydroxyvitamin D production in intrauterine phosphorus and calcium homeostasis. Pediatr Res. 1985 Jun; 19(6):566-9. PMID: 3839301.
      Citations: 4     Fields:    Translation:Animals
    200. Nakagawa Y, Parks JH, Coe FL, Kézdy FJ. Molecular abnormality of urinary glycoprotein crystal growth inhibitor in calcium nephrolithiasis. Trans Assoc Am Physicians. 1985; 98:281-9. PMID: 3842199.
      Citations: 4     Fields:    Translation:HumansCells
    201. Sutherland JW, Parks JH, Coe FL. Recurrence after a single renal stone in a community practice. Miner Electrolyte Metab. 1985; 11(4):267-9. PMID: 4033604.
      Citations: 43     Fields:    Translation:Humans
    202. Bushinsky DA, Coe FL. Hyperkalemia during acute ammonium chloride acidosis in man. Nephron. 1985; 40(1):38-40. PMID: 3923378.
      Citations: 3     Fields:    Translation:Humans
    203. Nakagawa Y, Abram V, Coe FL. Isolation of calcium oxalate crystal growth inhibitor from rat kidney and urine. Am J Physiol. 1984 Nov; 247(5 Pt 2):F765-72. PMID: 6496744.
      Citations: 8     Fields:    Translation:Animals
    204. Bushinsky DA, Favus MJ, Coe FL. Mechanism of chronic hypocalciuria with chlorthalidone: reduced calcium absorption. Am J Physiol. 1984 Nov; 247(5 Pt 2):F746-52. PMID: 6548610.
      Citations: 6     Fields:    Translation:Animals
    205. Kathpalia SC, Favus MJ, Coe FL. Evidence for size and charge permselectivity of rat ascending colon. Effects of ricinoleate and bile salts on oxalic acid and neutral sugar transport. J Clin Invest. 1984 Sep; 74(3):805-11. PMID: 6432849; PMCID: PMC425234.
      Citations: 6     Fields:    Translation:Animals
    206. Coe F. Treatment of hypercalciuria. N Engl J Med. 1984 Jul 12; 311(2):116-8. PMID: 6547507.
      Citations: 4     Fields:    Translation:Humans
    207. Coe FL, Bushinsky DA. Pathophysiology of hypercalciuria. Am J Physiol. 1984 Jul; 247(1 Pt 2):F1-13. PMID: 6377922.
      Citations: 20     Fields:    Translation:Humans
    208. Bushinsky DA, Favus MJ, Coe FL. Elevated 1,25(OH)2D3, intestinal absorption, and renal mineral conservation in male rats. Am J Physiol. 1984 Feb; 246(2 Pt 2):F140-5. PMID: 6546474.
      Citations: 4     Fields:    Translation:AnimalsCells
    209. Moore ES, Langman CB, Favus MJ, Schneider AB, Coe FL. Secondary hyperparathyroidism in children with symptomatic idiopathic hypercalciuria. J Pediatr. 1983 Dec; 103(6):932-5. PMID: 6644429.
      Citations: 1     Fields:    Translation:Humans
    210. Nakagawa Y, Abram V, Kaiser ET, Coe FL, Kézdy FJ. Purification and characterization of the principal inhibitor of calcium oxalate monohydrate crystal growth in human urine. J Biol Chem. 1983 Oct 25; 258(20):12594-600. PMID: 6630201.
      Citations: 42     Fields:    Translation:HumansCells
    211. Coe FL. Uric acid and calcium oxalate nephrolithiasis. Kidney Int. 1983 Sep; 24(3):392-403. PMID: 6645213.
      Citations: 14     Fields:    Translation:Humans
    212. Bushinsky DA, Krieger NS, Geisser DI, Grossman EB, Coe FL. Effects of pH on bone calcium and proton fluxes in vitro. Am J Physiol. 1983 Aug; 245(2):F204-9. PMID: 6881337.
      Citations: 26     Fields:    Translation:AnimalsCells
    213. Coe FL. Reflections on stones. West J Med. 1983 Apr; 138(4):558-60. PMID: 18749347; PMCID: PMC1010753.
      Citations:    Fields:    
    214. Favus MJ, Angeid-Backman E, Breyer MD, Coe FL. Effects of trifluoperazine, ouabain, and ethacrynic acid on intestinal calcium transport. Am J Physiol. 1983 Feb; 244(2):G111-5. PMID: 6687417.
      Citations: 11     Fields:    Translation:Animals
    215. Coe FL, Favus MJ. Idiopathic hypercalciuria. Henry Ford Hosp Med J. 1983; 31(4):229-30. PMID: 6689528.
      Citations:    Fields:    Translation:Humans
    216. Langman CB, Favus MJ, Bushinsky DA, Coe FL. Effects of calcium intake on 1,25-dihydroxyvitamin D3 net synthesis by rat proximal tubules. Trans Assoc Am Physicians. 1983; 96:225-33. PMID: 6093310.
      Citations:    Fields:    Translation:Animals
    217. Bushinsky DA, Favus MJ, Schneider AB, Sen PK, Sherwood LM, Coe FL. Effects of metabolic acidosis on PTH and 1,25(OH)2D3 response to low calcium diet. Am J Physiol. 1982 Dec; 243(6):F570-5. PMID: 6293313.
      Citations: 9     Fields:    Translation:Animals
    218. Millman S, Strauss AL, Parks JH, Coe FL. Pathogenesis and clinical course of mixed calcium oxalate and uric acid nephrolithiasis. Kidney Int. 1982 Oct; 22(4):366-70. PMID: 7176335.
      Citations: 7     Fields:    Translation:Humans
    219. Bushinsky DA, Coe FL, Katzenberg C, Szidon JP, Parks JH. Arterial PCO2 in chronic metabolic acidosis. Kidney Int. 1982 Sep; 22(3):311-4. PMID: 6816981.
      Citations: 3     Fields:    Translation:Humans
    220. Favus MJ, Coe FL, Kathpalia SC, Porat A, Sen PK, Sherwood LM. Effects of chlorothiazide on 1,25-dihydroxyvitamin D3, parathyroid hormone, and intestinal calcium absorption in the rat. Am J Physiol. 1982 Jun; 242(6):G575-81. PMID: 6896403.
      Citations: 5     Fields:    Translation:Animals
    221. Parks JH, Coe FL, Strauss AL. Calcium nephrolithiasis and medullary sponge kidney in women. N Engl J Med. 1982 May 06; 306(18):1088-91. PMID: 7070404.
      Citations: 10     Fields:    Translation:Humans
    222. Strauss AL, Coe FL, Parks JH. Formation of a single calcium stone of renal origin. Clinical and laboratory characteristics of patients. Arch Intern Med. 1982 Mar; 142(3):504-7. PMID: 7065787.
      Citations: 13     Fields:    Translation:Humans
    223. Strauss AL, Coe FL, Deutsch L, Parks JH. Factors that predict relapse of calcium nephrolithiasis during treatment: a prospective study. Am J Med. 1982 Jan; 72(1):17-24. PMID: 7058820.
      Citations: 23     Fields:    Translation:Humans
    224. Favus MJ, Coe FL, Kathpalia SC, Porat A, Sen PK, Sherwood LM. Effects of chlorothiazide administration and dietary calcium restriction on parathyroid function, vitamin D metabolism and intestinal calcium absorption in the rat. Adv Exp Med Biol. 1982; 151:501-7. PMID: 6897485.
      Citations:    Fields:    Translation:Animals
    225. Coe FL, Favus MJ, Crockett T, Strauss AL, Parks JH, Porat A, Gantt CL, Sherwood LM. Effects of low-calcium diet on urine calcium excretion, parathyroid function and serum 1,25(OH)2D3 levels in patients with idiopathic hypercalciuria and in normal subjects. Am J Med. 1982 Jan; 72(1):25-32. PMID: 6277190.
      Citations: 53     Fields:    Translation:Humans
    226. Coe FL. Prevention of kidney stones. Am J Med. 1981 Oct; 71(4):514-6. PMID: 7282739.
      Citations: 2     Fields:    Translation:Humans
    227. Favus MJ, Berelowitz M, Coe FL. Effects of somatostatin on intestinal calcium transport in the rat. Am J Physiol. 1981 Sep; 241(3):G215-21. PMID: 6116434.
      Citations: 1     Fields:    Translation:Animals
    228. Coe FL, Parks JH. Hyperuricosuria and calcium nephrolithiasis. Urol Clin North Am. 1981 Jun; 8(2):227-44. PMID: 7268958.
      Citations: 3     Fields:    Translation:HumansCells
    229. Favus MJ, Kathpalia SC, Coe FL. Kinetic characteristics of calcium absorption and secretion by rat colon. Am J Physiol. 1981 May; 240(5):G350-4. PMID: 6786109.
      Citations: 17     Fields:    Translation:Animals
    230. Nakagawa Y, Margolis HC, Yokoyama S, Kaiser ET, Coe FL, Kézdy FJ. Purification and characterization of a calcium oxalate monohydrate crystal growth inhibitor from human kidney tissue culture medium. J Biol Chem. 1981 Apr 25; 256(8):3936-44. PMID: 7217065.
      Citations: 20     Fields:    Translation:HumansCells
    231. Coe FL. Nephrolithiasis: causes, classification, and management. Hosp Pract (Hosp Ed). 1981 Apr; 16(4):33-45. PMID: 7193640.
      Citations:    Translation:Humans
    232. Favus MJ, Coe FL. [Vitamin D physiology and its application to disorders of calcium metabolism]. Recenti Prog Med. 1981 Feb; 70(2):119-40. PMID: 7027383.
      Citations:    Fields:    Translation:HumansAnimals
    233. Parks J, Coe F, Favus M. Hyperparathyroidism in nephrolithiasis. Arch Intern Med. 1980 Nov; 140(11):1479-81. PMID: 7436644.
      Citations: 9     Fields:    Translation:Humans
    234. Coe FL, Favus MJ. Idiopathic hypercalciuria in calcium nephrolithiasis. Dis Mon. 1980 Sep; 26(12):1-36. PMID: 6905773.
      Citations: 1     Fields:    Translation:Humans
    235. Coe FL, Parks JH, Strauss AL. Acclerated calcium nephrolithiasis. JAMA. 1980 Aug 22-29; 244(8):809-10. PMID: 7392192.
      Citations: 1     Fields:    Translation:Humans
    236. Fathizadeh A, Fretzin DF, Favus MJ, Coe FL. Primary hyperparathyroidism and basal cell nevus syndrome. Ann Intern Med. 1980 Jul; 93(1):147. PMID: 7396296.
      Citations:    Fields:    Translation:Humans
    237. Coe FL, Parks JH. Stone disease in hereditary distal renal tubular acidosis. Ann Intern Med. 1980 Jul; 93(1):60-1. PMID: 7396320.
      Citations: 6     Fields:    Translation:Humans
    238. Coe FL, Strauss AL, Tembe V, Le Dun S. Uric acid saturation in calcium nephrolithiasis. Kidney Int. 1980 May; 17(5):662-8. PMID: 7401461.
      Citations: 18     Fields:    Translation:Humans
    239. Sitrin MD, Rosenberg IH, Chawla K, Meredith S, Sellin J, Rabb JM, Coe F, Kirsner JB, Kraft SC. Nutritional and metabolic complications in a patient with Crohn's disease and ileal resection. Gastroenterology. 1980 May; 78(5 Pt 1):1069-79. PMID: 7380180.
      Citations: 3     Fields:    Translation:Humans
    240. Coe FL. Recurrence of renal stones. Lancet. 1980 Mar 22; 1(8169):651. PMID: 6102651.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    241. Favus MJ, Kathpalia SC, Coe FL, Mond AE. Effects of diet calcium and 1,25-dihydroxyvitamin D3 on colon calcium active transport. Am J Physiol. 1980 Feb; 238(2):G75-8. PMID: 7361902.
      Citations: 15     Fields:    Translation:Animals
    242. Coe FL, Favus MJ. Does mild, asymptomatic hyperparathyroidism require surgery? N Engl J Med. 1980 Jan 24; 302(4):224-5. PMID: 7350463.
      Citations: 12     Fields:    Translation:Humans
    243. Coe FL. Hyperuricosuric calcium oxalate nephrolithiasis. Adv Exp Med Biol. 1980; 128:439-50. PMID: 7424690.
      Citations: 1     Fields:    Translation:Humans
    244. Schwartz JS, Kempa JS, Vasilomanolakis EC, Szidon JP, Coe FL, Jao W. Viomycin-induced electrolyte abnormalities. Respiration. 1980; 40(5):284-92. PMID: 6262892.
      Citations: 2     Fields:    Translation:Humans
    245. Favus MJ, Coe FL. Clinical characteristics and pathogenetic mechanisms in hyperuricosuric calcium oxalate renal stone disease. Scand J Urol Nephrol Suppl. 1980; 53:171-7. PMID: 6937993.
      Citations: 1     Fields:    Translation:HumansCells
    246. Favus MJ, Coe FL. The effects of allopurinol treatment on stone formation on hyperuricosuric calcium oxalate stone-formers. Scand J Urol Nephrol Suppl. 1980; 53:265-71. PMID: 6938003.
      Citations: 5     Fields:    Translation:Humans
    247. Coe FL, Favus MJ. Treatment of renal calculi. Adv Intern Med. 1980; 26:373-92. PMID: 7013442.
      Citations:    Fields:    Translation:Humans
    248. Coe FL, Parks JH, Moore ES. Familial idiopathic hypercalciuria. N Engl J Med. 1979 Feb 15; 300(7):337-40. PMID: 759893.
      Citations: 53     Fields:    Translation:Humans
    249. Weber DV, Coe FL, Parks JH, Dunn MS, Tembe V. Urinary saturation measurements in calcium nephrolithiasis. Ann Intern Med. 1979 Feb; 90(2):180-4. PMID: 443649.
      Citations: 8     Fields:    Translation:Humans
    250. Coe FL. An inventory of our therapeutic possessions. Med Clin North Am. 1978 Nov; 62(6):1147-56. PMID: 84097.
      Citations:    Fields:    Translation:Humans
    251. Coe FL. Symposium on renal therapeutics. Foreword. Med Clin North Am. 1978 Nov; 62(6):1145. PMID: 368442.
      Citations:    Fields:    Translation:Humans
    252. Nakagawa Y, Kaiser ET, Coe FL. Isolation and characterization of calcium oxalate crystal growth inhibitors from human urine. Biochem Biophys Res Commun. 1978 Oct 30; 84(4):1038-44. PMID: 728143.
      Citations: 10     Fields:    Translation:HumansCells
    253. Coe FL. Calcium-uric acid nephrolithiasis. Arch Intern Med. 1978 Jul; 138(7):1090-3. PMID: 666467.
      Citations: 1     Fields:    Translation:Humans
    254. Moore ES, Coe FL, McMann BJ, Favus MJ. Idiopathic hypercalciuria in children: prevalence and metabolic characteristics. J Pediatr. 1978 Jun; 92(6):906-10. PMID: 660355.
      Citations: 28     Fields:    Translation:Humans
    255. Coe FL. Hyperuricosuric calcium oxalate nephrolithiasis. Kidney Int. 1978 May; 13(5):418-26. PMID: 661071.
      Citations: 25     Fields:    Translation:HumansCells
    256. Coe FL, Parks JH, Lindheimer MD. Nephrolithiasis during pregnancy. N Engl J Med. 1978 Feb 09; 298(6):324-6. PMID: 622090.
      Citations: 10     Fields:    Translation:Humans
    257. Coe FL. Metabolic alkalosis. JAMA. 1977 Nov 21; 238(21):2288-90. PMID: 578849.
      Citations:    Fields:    Translation:HumansCells
    258. Ito H, Coe FL. Acidic peptide and polyribonucleotide crystal growth inhibitors in human urine. Am J Physiol. 1977 Nov; 233(5):F455-63. PMID: 920814.
      Citations: 17     Fields:    Translation:HumansCells
    259. Blum JE, Coe FL. Metabolic acidosis after sulfur ingestion. N Engl J Med. 1977 Oct 20; 297(16):869-70. PMID: 904661.
      Citations: 1     Fields:    Translation:Humans
    260. Coe FL, Keck J, Norton ER. The natural history of calcium urolithiasis. JAMA. 1977 Oct 03; 238(14):1519-23. PMID: 578220.
      Citations: 25     Fields:    Translation:Humans
    261. Coe FL. Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercalciuria, hyperuricosuria, or no metabolic disorder. Ann Intern Med. 1977 Oct; 87(4):404-10. PMID: 907239.
      Citations: 45     Fields:    Translation:Humans
    262. Gaeke RF, Kaplan EL, Lindheimer MD, Coe F, Shen KL. Maternal primary hyperparathyroidism of pregnancy. Successful treatment by parathyroidectomy. JAMA. 1977 Aug 08; 238(6):508-9. PMID: 577577.
      Citations: 3     Fields:    Translation:Humans
    263. Coe FL, Norton E, Oparil S, Tatar A, Pullman TN. Treatment of hypertension by computer and physician-a prospective controlled study. J Chronic Dis. 1977 Feb; 30(2):81-92. PMID: 838839.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    264. Coe FL, Moran E, Kavalich AG. The contribution of dietary purine over-consumption to hyperpuricosuria in calcium oxalate stone formers. J Chronic Dis. 1976 Dec; 29(12):793-800. PMID: 1010873.
      Citations: 11     Fields:    Translation:Humans
    265. Lehne C, Coe FL. Compensatory phosphaturia after unilateral nephrectomy in the rat. Am J Physiol. 1976 Nov; 231(5 Pt. 1):1625-9. PMID: 998808.
      Citations:    Fields:    Translation:Animals
    266. Coe FL, Firpo JJ. Evidence for mild reversible hyperparathyroidism in distal renal tubular acidosis. Arch Intern Med. 1975 Nov; 135(11):1485-9. PMID: 1190933.
      Citations: 5     Fields:    Translation:Humans
    267. Coe FL, Firpo JJ, Hollandsworth DL, Segil L, Canterbury JM, Reiss E. Effect of acute and chronic metabolic acidosis on serum immunoreactive parathyroid hormone in man. Kidney Int. 1975 Oct; 8(4):263-73. PMID: 1202255.
      Citations: 16     Fields:    Translation:Humans
    268. Coe FL, Lawton RL, Goldstein RB, Tembe V. Sodium urate accelerates precipitation of calcium oxalate in vitro. Proc Soc Exp Biol Med. 1975 Sep; 149(4):926-9. PMID: 241080.
      Citations: 17     Fields:    Translation:Cells
    269. Coe FL, Kavalach AG. Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis. N Engl J Med. 1974 Dec 19; 291(25):1344-50. PMID: 4610395.
      Citations: 39     Fields:    Translation:Humans
    270. Coe FL. Magnitude of metabolic acidosis in primary hyperparathyroidism. Arch Intern Med. 1974 Aug; 134(2):262-5. PMID: 4843192.
      Citations: 2     Fields:    Translation:Humans
    271. McCarty DJ, Silcox DC, Coe F, Jacobelli S, Reiss E, Genant H, Ellman M. Diseases associated with calcium pyrophosphate dihydrate crystal deposition. Am J Med. 1974 May; 56(5):704-14. PMID: 4825605.
      Citations: 16     Fields:    Translation:Humans
    272. Coe FL. The performance of a computer system for metabolic assessment of patients with nephrolithiasis. Comput Biomed Res. 1974 Feb; 7(1):40-55. PMID: 4593725.
      Citations:    Fields:    Translation:Humans
    273. Coe FL, Raisen L. Allopurinol treatment of uric-acid disorders in calcium-stone formers. Lancet. 1973 Jan 20; 1(7795):129-31. PMID: 4118468.
      Citations: 12     Fields:    Translation:Humans
    274. Pullman TN, Coe FL. Chronic renal failure. Clin Symp. 1973; 25(1):2-32. PMID: 4354517.
      Citations:    Fields:    Translation:Humans
    275. Coe FL, Canterbury JM, Firpo JJ, Reiss E. Evidence for secondary hyperparathyroidism in idiopathic hypercalciuria. J Clin Invest. 1973 Jan; 52(1):134-42. PMID: 4682379; PMCID: PMC302235.
      Citations: 52     Fields:    Translation:Humans
    276. Coe FL, Canterbury J, Reiss E. Hyperparathyroidism in idiopathic hypercalciuria: primary or secondary? Trans Assoc Am Physicians. 1971; 84:152-61. PMID: 5164300.
      Citations: 3     Fields:    Translation:Humans
    277. Coe FL. A diagnostic approach to the patient with renal stones. Med Times. 1970 Oct; 98(10):87-94. PMID: 5506397.
      Citations:    Fields:    Translation:Humans
    278. Farquhar JK, Scott WN, Coe FL. Hexose monophosphate shunt activity in compensatory renal hypertrophy. Proc Soc Exp Biol Med. 1968 Dec; 129(3):809-12. PMID: 5725099.
      Citations: 4     Fields:    Translation:Animals
    279. Coe FL, Howe RW, Goetting JA. Mechanism of monomethylhydrazine excretion by the mammalian kidney. J Pharmacol Exp Ther. 1968 Sep; 163(1):216-21. PMID: 5673709.
      Citations:    Fields:    Translation:AnimalsCells
    280. Coe FL, Korty PR. The effect of hydrazine upon renal excretion of sodium, potassium and water. J Pharmacol Exp Ther. 1968 May; 161(1):183-90. PMID: 5648496.
      Citations:    Fields:    Translation:Animals
    281. Coe FL, Korty PR. Protein synthesis during compensatory renal hypertrophy. Am J Physiol. 1967 Dec; 213(6):1585-9. PMID: 6075761.
      Citations: 9     Fields:    Translation:AnimalsCells
    282. Coe FL, Korty PR. Mechanism of hydrazine excretion by the mammalian kidney. Am J Physiol. 1967 Feb; 212(2):394-9. PMID: 6018024.
      Citations: 2     Fields:    Translation:Animals
    283. Burke G, Halko A, Coe FL. Dynamic clinical studies with radioisotopes and the scintillation camera. I. Sodium iodohippurate I-131 renography. JAMA. 1966 Jul 04; 197(1):15-24. PMID: 5952531.
      Citations: 1     Fields:    Translation:Humans
    284. Kallen RJ, Zaltzman S, Coe FL, Metcoff J. Hemodialysis in children: technique, kinetic aspects related to varying body size, and application to salicylate intoxication, acute renal failure and some other disorders. Medicine (Baltimore). 1966 Jan; 45(1):1-50. PMID: 5323449.
      Citations: 2     Fields:    Translation:Humans
    Coe's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (618)
    Explore
    _
    Co-Authors (20)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _